VULVAR ADENOCARCINOMA
Clinical trials for VULVAR ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New smart chemo targets tumors, spares healthy tissue
Disease control Recruiting nowThis early-phase trial tests a new drug called AVA6103 in 174 people with advanced solid tumors (like pancreatic, stomach, or lung cancer) that have not responded to standard treatments. The drug is designed to activate only inside tumors, potentially killing cancer cells while r…
Matched conditions: VULVAR ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug combo aims to fight Hard-to-Treat vulvar cancer
Disease control Recruiting nowThis Phase 2 trial is testing whether two drugs, pembrolizumab and lenvatinib, can shrink or control vulvar cancer that cannot be surgically removed. About 80 participants will receive the combination in 21-day cycles. The study will measure tumor response and track side effects.
Matched conditions: VULVAR ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC